|
SUZ12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.47079999980005E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71966999999995E-05 |
| Normal-vs-Stage2 |
1.664650E-03 |
| Normal-vs-Stage3 |
3.43430000004918E-06 |
| Normal-vs-Stage4 |
4.06689999998822E-06 |
| Stage1-vs-Stage2 |
7.734600E-01 |
| Stage1-vs-Stage3 |
4.018200E-01 |
| Stage1-vs-Stage4 |
2.131600E-01 |
| Stage2-vs-Stage3 |
4.115400E-01 |
| Stage2-vs-Stage4 |
2.317400E-01 |
| Stage3-vs-Stage4 |
5.795200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.98289999998292E-07 |
| Normal-vs-AfricanAmerican |
9.137900E-03 |
| Normal-vs-Asian |
1.70505999999016E-05 |
| Caucasian-vs-AfricanAmerican |
5.829200E-01 |
| Caucasian-vs-Asian |
5.286800E-01 |
| AfricanAmerican-vs-Asian |
3.434400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.85819999948467E-07 |
| Normal-vs-Female |
1.57036999999249E-05 |
| Male-vs-Female |
2.007800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.558000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.35109999965799E-07 |
| Normal-vs-Age(61-80Yrs) |
1.390310E-04 |
| Normal-vs-Age(81-100Yrs) |
2.558000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.490300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.748000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.307800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.779440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.375400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.654600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.043200E-01 |
| Classical-VS-Follicular |
8.109000E-01 |
| Classical-VS-Other |
2.058000E-01 |
| Classical-VS-Normal |
2.09839999999462E-05 |
| Tall-VS-Follicular |
6.613200E-01 |
| Tall-VS-Other |
3.287200E-01 |
| Tall-VS-Normal |
4.005100E-04 |
| Follicular-VS-Other |
2.851400E-01 |
| Follicular-VS-Normal |
3.183200E-04 |
| Other-VS-Normal |
2.975600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.07879999999838E-06 |
| Normal-vs-N1 |
2.24689999999139E-05 |
| N0-vs-N1 |
5.120000E-01 |
|
|
